Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IronMother
2024-512064-61-00Phase 4Completed
- Sponsor
- University College Dublin
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ferrous fumarate in iron deficiency anemia (IDA) (2 arms), sponsored by University College Dublin. Primary endpoint: Haemoglobin levels at 4 weeks post investigational medicinal product treatment. Started May 2024; status: completed.
02
Drugs
ferrous fumarate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2024-512064-61-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512064-61-00.